These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 475846)

  • 1. Cyclophosphamide cystitis--identification of acrolein as the causative agent.
    Cox PJ
    Biochem Pharmacol; 1979 Jul; 28(13):2045-9. PubMed ID: 475846
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide cystitis. Studies aimed at its minimization.
    Cox PJ; Abel G
    Biochem Pharmacol; 1979 Dec; 28(24):3499-502. PubMed ID: 231445
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental cytoxan cystitis and prevention by acetylcysteine.
    Chaviano AH; Gill WB; Ruggiero KJ; Vermeulen CW
    J Urol; 1985 Sep; 134(3):598-600. PubMed ID: 4032564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide.
    Wang CC; Weng TI; Wu ET; Wu MH; Yang RS; Liu SH
    Toxicol Sci; 2013 Jan; 131(1):302-10. PubMed ID: 22961095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity.
    Levy L; Vredevoe DL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):7-16. PubMed ID: 6836330
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-induced cystitis of the urinary bladder of rats and its treatment.
    Tolley DA; Castro JE
    Proc R Soc Med; 1975 Mar; 68(3):169-70. PubMed ID: 1166056
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis.
    Macedo FY; Baltazar F; Mourão LC; Almeida PR; Mota JM; Schmitt FC; Ribeiro RA
    Exp Toxicol Pathol; 2008 Apr; 59(6):425-30. PubMed ID: 18234483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat urinary bladder epithelial lesions induced by acrolein.
    Sakata T; Smith RA; Garland EM; Cohen SM
    J Environ Pathol Toxicol Oncol; 1989; 9(2):159-69. PubMed ID: 2732910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.
    Conklin DJ; Haberzettl P; Lesgards JF; Prough RA; Srivastava S; Bhatnagar A
    J Pharmacol Exp Ther; 2009 Nov; 331(2):456-69. PubMed ID: 19696094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 11. A model of hemorrhagic cystitis induced with acrolein in mice.
    Batista CK; Brito GA; Souza ML; Leitão BT; Cunha FQ; Ribeiro RA
    Braz J Med Biol Res; 2006 Nov; 39(11):1475-81. PubMed ID: 17146560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of cyclophosphamide-induced cystitis in mice by disulfiram.
    Hacker MP; Newman RA; Ershler WB
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):145-54. PubMed ID: 7058285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis.
    Haldar S; Dru C; Mishra R; Tripathi M; Duong F; Angara B; Fernandez A; Arditi M; Bhowmick NA
    Sci Rep; 2016 Dec; 6():39257. PubMed ID: 27995963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder.
    Ahluwalia A; Maggi CA; Santicioli P; Lecci A; Giuliani S
    Br J Pharmacol; 1994 Apr; 111(4):1017-22. PubMed ID: 8032584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis.
    Malley SE; Vizzard MA
    Physiol Genomics; 2002; 9(1):5-13. PubMed ID: 11948286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy.
    Gray KJ; Engelmann UH; Johnson EH; Fishman IJ
    J Urol; 1986 Aug; 136(2):497-500. PubMed ID: 3090278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N; Stekar J; Pohl J; Niemeyer U; Scheffler G
    Arzneimittelforschung; 1979; 29(4):659-61. PubMed ID: 114192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcysteine in the prevention of cyclophosphamide-induced cystitis in rats.
    Botta JA; Nelson LW; Weikel JH
    J Natl Cancer Inst; 1973 Sep; 51(3):1051-8. PubMed ID: 4743552
    [No Abstract]   [Full Text] [Related]  

  • 19. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.